Charles Schwab Investment Management Inc Fortress Biotech, Inc. Transaction History

Charles Schwab Investment Management Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.8 - $1.5 $135,606 - $254,262	-169,508 Reduced 84.98%	29,965 $26,000
Q1 2022 May 13, 2022	BUY	$1.24 - $2.75 $16,077 - $35,656	12,966 Added 6.95%	199,473 $272,000
Q3 2021 Nov 16, 2021	BUY	$2.82 - $3.7 $24,768 - $32,497	8,783 Added 4.94%	186,507 $601,000
Q2 2021 Aug 16, 2021	BUY	$3.5 - $5.48 $24,878 - $38,951	7,108 Added 4.17%	177,724 $635,000
Q1 2021 May 17, 2021	BUY	$3.16 - $4.89 $1,624 - $2,513	514 Added 0.3%	170,616 $603,000

Q4 2020 Feb 16, 2021	BUY	$2.2 - $4.45 $21,824 - $44,144	9,920 Added 6.19%	170,102 $540,000
Q3 2020 Nov 13, 2020	BUY	$2.62 - $4.78 $13,110 - $23,919	5,004 Added 3.22%	160,182 $648,000
Q2 2020 Aug 14, 2020	BUY	$1.83 - $3.16 $283,975 - $490,362	155,178 New	155,178 $416,000
Q2 2019 Aug 09, 2019	SELL	$1.43 - $1.94 $108,183 - $146,766	-75,653 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$0.94 - $2.47 $17,627 - $46,319	18,753 Added 32.96%	75,653 $135,000
Q3 2017 Nov 13, 2017	BUY	$3.83 - $4.89 $217,927 - $278,241	56,900	56,900 $252,000

1.01M

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $194M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.